Collects body cell samples from people with neurological diseases for research
Collects skin or blood samples from people with ALS, Alzheimer disease, or Batten disease.
Key facts
- Who runs it
- New York Stem Cell Foundation Research Institute
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- NYSCF Scientific Discovery Biobank
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 10 Nov 2022
- Expected to end
- 10 Nov 2045
- Type of study
- Observational, 2 groups
- Treatments tested
- Biological Sample Collection
- Record updated
- 3 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 30 days or older who have a condition, disease, genetic background or trait of interest, or who are healthy controls. Cells such as skin or blood are collected for research and stored.
- Age
- 30 days or older.
- Sex
- All sexes can join.
Main reasons for not taking part
- Wards of the state.
- For skin samples: history of keloid formation, a coagulation disorder, or allergy to the anesthetic.
- For blood samples: history of a coagulation disorder.
- People who refuse to follow NYSCF's or the collection site's safety protocols.
- People with an AIDS diagnosis and a CD4 count of less than 200 cells per microliter (mcL) of blood.
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age 30 days or older
- Diagnosis and/or medical history of a condition, disease, genetic background, or trait of interest or healthy control
- Adults with decisional capacity must provide written informed consent unless physical limitations preclude signing
- Adults without decisional capacity to consent must a have diagnosis of Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease and Related Dementias (AD/ADRD); Batten Disease, Corticobasal Degeneration (CBD), Dementia, Frontotemporal Dementia (FTD), Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy, Parkinson's Disease (PD), Parkinsonism, and/or Progressive Supranuclear Palsy, and must provide assent; a legally authorized representative (LAR) must also provide written informed consent
- Minors undergoing skin collection for research purposes must have a condition, disease, genetic background, or trait of interest and parental/guardian consent
- Minors undergoing blood, and/or saliva collection for research purposes may have a condition, disease, genetic background, or trait of interest or serve as a healthy control and must have an available parent/guardian to provide consent
- Minors transferring biological samples and associated data from a procedure outside of the research may have a condition, disease, genetic background, or trait of interest or serve as a healthy control and must have an available parent/guardian to provide consent
Who cannot take part
- For prospective skin samples: history of keloid formation, coagulation disorder, or allergy to the anesthetic
- For prospective blood samples: history of coagulation disorder
- For all prospective sample collections: 1) Subjects who refuse to adhere to NYSCF's and/or a collection site's safety protocol(s) will be excluded; 2) Subjects with an AIDS diagnosis and CD4 count of less than 200 cells per microliter (mcL) of blood will be excluded due to increased risk of infection
- Wards of the state
Where in United States
- New York Stem Cell Foundation Research InstituteNew York, United StatesContact: Clinical Research OfficeTaking people
About the trial
What the trial wants to find out
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the samples for future use.
Read full original descriptionShow less
Through this research, researchers hope to identify future treatments or even cures for the major diseases of our time.
The 2 groups in the trial
- Affected Subjects
Subjects in this group will have a diagnosis and/or medical history of a condition, disease, genetic background, or trait of interest.
Treatment: Biological Sample Collection
- Healthy Control
Subjects in this group will serve as healthy controls.
Treatment: Biological Sample Collection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- NYSCF Scientific Discovery Biobank
- Plain-language title
- Collects body cell samples from people with neurological diseases for researchGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 3 March 2025